These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8229148)

  • 1. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
    Barcs I
    J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of clindamycin and lincomycin.
    Easmon CS; Crane JP
    Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
    Bassler M; Just HM; Richter A; Zeller H; Daschner F
    Infection; 1984; 12(4):280-5. PubMed ID: 6490174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
    Leclercq R; Carlier C; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1985 Sep; 28(3):421-4. PubMed ID: 3907492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025.
    Bozdogan B; Berrezouga L; Kuo MS; Yurek DA; Farley KA; Stockman BJ; Leclercq R
    Antimicrob Agents Chemother; 1999 Apr; 43(4):925-9. PubMed ID: 10103201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin.
    Watanakunakorn C
    Am J Med; 1976 Mar; 60(3):419-25. PubMed ID: 1045861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes.
    Brisson-Noël A; Delrieu P; Samain D; Courvalin P
    J Biol Chem; 1988 Nov; 263(31):15880-7. PubMed ID: 2846528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36.
    Achard A; Villers C; Pichereau V; Leclercq R
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2716-9. PubMed ID: 15980341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 12. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental passage of erythromycin and clindamycin.
    Philipson A; Sabath LD; Charles D
    N Engl J Med; 1973 Jun; 288(23):1219-21. PubMed ID: 4700555
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.
    Reeves DS; Holt HA; Phillips I; King A; Miles RS; Paton R; Wise R; Andrews JM
    J Antimicrob Chemother; 1991 Apr; 27(4):469-74. PubMed ID: 1856126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives.
    Pestka S; Vince R; LeMahieu R; Weiss F; Fern L; Unowsky J
    Antimicrob Agents Chemother; 1976 Jan; 9(1):128-30. PubMed ID: 1259386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of enzyme synthesis by lincomycin in Staphylococcus aureus.
    Shibl AM
    J Antimicrob Chemother; 1984 Jun; 13(6):625-7. PubMed ID: 6469883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and expression of the staphylococcal constitutive macrolide-lincosamide-streptogramin B resistance plasmid pE3692 in Staphylococcus aureus and Bacillus subtilis.
    Wieckiewicz J; Wójcik K
    J Basic Microbiol; 1989; 29(2):93-8. PubMed ID: 2496222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE; Gemmell CG
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
    Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
    J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.